ANPEP and Alzheimer disease: To study whether liver-specific overexpression of trimeric APN results in an increased level of cerebral APN for chronic treatment of AD, the single dose at 1 × 1011 GC was chosen for intravenous injection into 4-month old 5xFAD mice (Fig. 4a).